FilingReader Intelligence
Alembic Pharmaceuticals reports 10% revenue growth in Q1
August 11, 2025 at 07:08 PM UTC•By FilingReader AI
Alembic Pharmaceuticals reported Q1 FY'26 revenue of Rs. 1,711 crores, up 10% year-on-year. Gross margin improved to 76.2% from 74.8%, while net profit rose 15% to Rs. 154 crores.
The company expects 10%-15% growth in its US business with 10-15 new product launches planned. India branded business grew 5% year-on-year, though the API business remained flat due to pricing pressure.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:APLLTD•Bombay Stock Exchange
News Alerts
Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime